These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 20609201)
61. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases. Ojeda-Uribe M; Afif N; Dahan E; Sparsa L; Haby C; Sibilia J; Ternant D; Ardizzone M Clin Rheumatol; 2013 May; 32(5):695-700. PubMed ID: 23292481 [TBL] [Abstract][Full Text] [Related]
62. Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports. Iioka F; Shimomura D; Ishii T; Maesako Y; Ohgoe K; Nakamura F; Matsuo S; Ohno H Int J Hematol; 2012 Oct; 96(4):506-12. PubMed ID: 22878941 [TBL] [Abstract][Full Text] [Related]
63. Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis. Tun NM; Villani GM J Thromb Thrombolysis; 2012 Oct; 34(3):347-59. PubMed ID: 22547089 [TBL] [Abstract][Full Text] [Related]
64. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395 [TBL] [Abstract][Full Text] [Related]
65. Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease. TreliĆski J; Chojnowski K; Kurenko-Deptuch M; Kasznicki M; Bernatowska E; Robak T Ann Hematol; 2005 Nov; 84(12):835-6. PubMed ID: 16078034 [No Abstract] [Full Text] [Related]
66. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292 [TBL] [Abstract][Full Text] [Related]
67. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
68. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura. Ojeda-Uribe M; Federici L; Wolf M; Coppo P; Veyradier A Transfusion; 2010 Mar; 50(3):733-5. PubMed ID: 20609201 [No Abstract] [Full Text] [Related]
69. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura? Cooper N; Evangelista ML; Amadori S; Stasi R Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569 [TBL] [Abstract][Full Text] [Related]
70. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab. Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381 [TBL] [Abstract][Full Text] [Related]